These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8630409)

  • 1. Activation of Hodgkin cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-kappabeta transcription factor.
    Gruss HJ; Ulrich D; Dower SK; Herrmann F; Brach MA
    Blood; 1996 Mar; 87(6):2443-9. PubMed ID: 8630409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD30-IL-12 antibody-cytokine fusion protein that induces IFN-gamma secretion of T cells and NK cell-mediated lysis of Hodgkin's lymphoma-derived tumor cells.
    Heuser C; Diehl V; Abken H; Hombach A
    Int J Cancer; 2003 Sep; 106(4):545-552. PubMed ID: 12845650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30 ligation induces nuclear factor-kappa B activation in human T cell lines.
    McDonald PP; Cassatella MA; Bald A; Maggi E; Romagnani S; Gruss HJ; Pizzolo G
    Eur J Immunol; 1995 Oct; 25(10):2870-6. PubMed ID: 7589085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
    Gruss H-J ; Herrmann F
    Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.
    Horie R; Watanabe T; Morishita Y; Ito K; Ishida T; Kanegae Y; Saito I; Higashihara M; Mori S; Kadin ME; Watanabe T
    Oncogene; 2002 Apr; 21(16):2493-503. PubMed ID: 11971184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells.
    Bargou RC; Leng C; Krappmann D; Emmerich F; Mapara MY; Bommert K; Royer HD; Scheidereit C; Dörken B
    Blood; 1996 May; 87(10):4340-7. PubMed ID: 8639794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells.
    Gruss HJ; Brach MA; Drexler HG; Bonifer R; Mertelsmann RH; Herrmann F
    Cancer Res; 1992 Jun; 52(12):3353-60. PubMed ID: 1596893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hodgkin disease: pharmacologic intervention of the CD40-NF kappa B pathway by a protease inhibitor.
    Annunziata CM; Safiran YJ; Irving SG; Kasid UN; Cossman J
    Blood; 2000 Oct; 96(8):2841-8. PubMed ID: 11023520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation of binding sites for STAT6 and NF kappa B/rel in the IL-4-induced up-regulation of the human IgE germline promoter.
    Messner B; Stütz AM; Albrecht B; Peiritsch S; Woisetschläger M
    J Immunol; 1997 Oct; 159(7):3330-7. PubMed ID: 9317131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells.
    Mir SS; Richter BW; Duckett CS
    Blood; 2000 Dec; 96(13):4307-12. PubMed ID: 11110706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40 induces interleukin-6 gene transcription in dendritic cells: regulation by TRAF2, AP-1, NF-kappa B, AND CBF1.
    Mann J; Oakley F; Johnson PW; Mann DA
    J Biol Chem; 2002 May; 277(19):17125-38. PubMed ID: 11886848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD30 ligand and CD40 ligand regulate CD54 surface expression and release of its soluble form by cultured Hodgkin and Reed-Sternberg cells.
    Gruss HJ; Scheffrahn I; Hubinger G; Duyster J; Hermann F
    Leukemia; 1996 May; 10(5):829-35. PubMed ID: 8656679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
    Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
    Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kappa B enhancer of the human interleukin-6 promoter is necessary and sufficient to confer an IL-1 beta and TNF-alpha response in transfected human cell lines: requirement for members of the C/EBP family for activity.
    Merola M; Blanchard B; Tovey MG
    J Interferon Cytokine Res; 1996 Oct; 16(10):783-98. PubMed ID: 8910763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a chimeric T-cell receptor with specificity for the Hodgkin's lymphoma-associated CD30 antigen.
    Hombach A; Heuser C; Sircar R; Tillmann T; Diehl V; Pohl C; Abken H
    J Immunother; 1999 Nov; 22(6):473-80. PubMed ID: 10570745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease.
    Gruss HJ; Hirschstein D; Wright B; Ulrich D; Caligiuri MA; Barcos M; Strockbine L; Armitage RJ; Dower SK
    Blood; 1994 Oct; 84(7):2305-14. PubMed ID: 7522624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma.
    Dong G; Chen Z; Kato T; Van Waes C
    Cancer Res; 1999 Jul; 59(14):3495-504. PubMed ID: 10416616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of new ricin A-chain immunotoxins with potent anti-tumor effects against human Hodgkin cells in vitro and disseminated Hodgkin tumors in SCID mice using high-affinity monoclonal antibodies directed against the CD30 antigen.
    Schnell R; Linnartz C; Katouzi AA; Schön G; Bohlen H; Horn-Lohrens O; Parwaresch RM; Lange H; Diehl V; Lemke H
    Int J Cancer; 1995 Oct; 63(2):238-44. PubMed ID: 7591211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interleukin 2 CD28-responsive complex contains at least three members of the NF kappa B family: c-Rel, p50, and p65.
    Ghosh P; Tan TH; Rice NR; Sica A; Young HA
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1696-700. PubMed ID: 8383323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.